Cargando…

Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis

Acute alcoholic microvesicular steatosis (MIC) may complicate heavy alcohol intake and present as alcoholic hepatitis (AH) syndrome. However, detailed clinical, biological, and histologic data associated with MIC are scarce. We compared the clinical presentation, histologic features, and hepatic tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Spahr, Laurent, Lanthier, Nicolas, Tihy, Mathieu, Frossard, Jean‐Louis, Rubbia‐Brandt, Laura, Goossens, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034579/
https://www.ncbi.nlm.nih.gov/pubmed/33860120
http://dx.doi.org/10.1002/hep4.1669
_version_ 1783676564384251904
author Spahr, Laurent
Lanthier, Nicolas
Tihy, Mathieu
Frossard, Jean‐Louis
Rubbia‐Brandt, Laura
Goossens, Nicolas
author_facet Spahr, Laurent
Lanthier, Nicolas
Tihy, Mathieu
Frossard, Jean‐Louis
Rubbia‐Brandt, Laura
Goossens, Nicolas
author_sort Spahr, Laurent
collection PubMed
description Acute alcoholic microvesicular steatosis (MIC) may complicate heavy alcohol intake and present as alcoholic hepatitis (AH) syndrome. However, detailed clinical, biological, and histologic data associated with MIC are scarce. We compared the clinical presentation, histologic features, and hepatic transcriptomic of patients presenting with AH due to either MIC or severe alcoholic steatohepatitis (ASH). In this case‐control study, patients who drank heavily (>100 g/day) with the AH syndrome were included either in the MIC group (>50% severe microvesicular steatosis, no inflammation) or in the severe ASH group (polynuclear neutrophil infiltration, macrosteatosis, ballooned hepatocytes). All patients received standard supportive care plus steroids for those with severe ASH and were followed up for 3 months. Whole‐liver transcriptome profiling was performed on liver snap‐frozen biopsies. Compared to ASH (n = 24, mean age 49.3 years), patients in the MIC group (n = 12, mean age 49.1 years) had a higher reported alcohol intake (P < 0.01), lower Model for End‐Stage Liver Disease score (P < 0.05), lower hepatic venous pressure gradient (P < 0.01), higher alanine aminotransferase (P < 0.02) and gamma‐glutamyltransferase (P < 0.001), higher triglycerides (P < 0.001) and total cholesterol (P < 0.002), but similar bilirubin levels (P = 0.54). At histology, patients with MIC had a lower fibrotic stage compared to those with ASH (P < 0.001). A higher density of megamitochondria was seen in MIC compared to ASH (P < 0.05). During follow‐up, death or transplantation occurred in 4/12 (33%) patients with MIC and 7/24 (29%) patients with severe ASH. Differential hepatic gene expression in MIC compared to ASH included down‐regulation of genes related to inflammation and fibrosis and up‐regulation of genes involved in lipid metabolism and mitochondrial function. Conclusion: MIC is an acute, noninflammatory, potentially severe alcoholic liver injury mimicking ASH, is associated with a lower fibrosis stage, and has a distinct gene expression profile.
format Online
Article
Text
id pubmed-8034579
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80345792021-04-14 Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis Spahr, Laurent Lanthier, Nicolas Tihy, Mathieu Frossard, Jean‐Louis Rubbia‐Brandt, Laura Goossens, Nicolas Hepatol Commun Original Articles Acute alcoholic microvesicular steatosis (MIC) may complicate heavy alcohol intake and present as alcoholic hepatitis (AH) syndrome. However, detailed clinical, biological, and histologic data associated with MIC are scarce. We compared the clinical presentation, histologic features, and hepatic transcriptomic of patients presenting with AH due to either MIC or severe alcoholic steatohepatitis (ASH). In this case‐control study, patients who drank heavily (>100 g/day) with the AH syndrome were included either in the MIC group (>50% severe microvesicular steatosis, no inflammation) or in the severe ASH group (polynuclear neutrophil infiltration, macrosteatosis, ballooned hepatocytes). All patients received standard supportive care plus steroids for those with severe ASH and were followed up for 3 months. Whole‐liver transcriptome profiling was performed on liver snap‐frozen biopsies. Compared to ASH (n = 24, mean age 49.3 years), patients in the MIC group (n = 12, mean age 49.1 years) had a higher reported alcohol intake (P < 0.01), lower Model for End‐Stage Liver Disease score (P < 0.05), lower hepatic venous pressure gradient (P < 0.01), higher alanine aminotransferase (P < 0.02) and gamma‐glutamyltransferase (P < 0.001), higher triglycerides (P < 0.001) and total cholesterol (P < 0.002), but similar bilirubin levels (P = 0.54). At histology, patients with MIC had a lower fibrotic stage compared to those with ASH (P < 0.001). A higher density of megamitochondria was seen in MIC compared to ASH (P < 0.05). During follow‐up, death or transplantation occurred in 4/12 (33%) patients with MIC and 7/24 (29%) patients with severe ASH. Differential hepatic gene expression in MIC compared to ASH included down‐regulation of genes related to inflammation and fibrosis and up‐regulation of genes involved in lipid metabolism and mitochondrial function. Conclusion: MIC is an acute, noninflammatory, potentially severe alcoholic liver injury mimicking ASH, is associated with a lower fibrosis stage, and has a distinct gene expression profile. John Wiley and Sons Inc. 2021-01-09 /pmc/articles/PMC8034579/ /pubmed/33860120 http://dx.doi.org/10.1002/hep4.1669 Text en © 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of the American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Spahr, Laurent
Lanthier, Nicolas
Tihy, Mathieu
Frossard, Jean‐Louis
Rubbia‐Brandt, Laura
Goossens, Nicolas
Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title_full Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title_fullStr Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title_full_unstemmed Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title_short Clinical Presentation and Gene Expression of Acute Alcohol‐Induced Microvesicular Steatosis Mimicking Alcoholic Hepatitis
title_sort clinical presentation and gene expression of acute alcohol‐induced microvesicular steatosis mimicking alcoholic hepatitis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034579/
https://www.ncbi.nlm.nih.gov/pubmed/33860120
http://dx.doi.org/10.1002/hep4.1669
work_keys_str_mv AT spahrlaurent clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis
AT lanthiernicolas clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis
AT tihymathieu clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis
AT frossardjeanlouis clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis
AT rubbiabrandtlaura clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis
AT goossensnicolas clinicalpresentationandgeneexpressionofacutealcoholinducedmicrovesicularsteatosismimickingalcoholichepatitis